ATE234859T1 - Peptid-derivat - Google Patents

Peptid-derivat

Info

Publication number
ATE234859T1
ATE234859T1 AT99944809T AT99944809T ATE234859T1 AT E234859 T1 ATE234859 T1 AT E234859T1 AT 99944809 T AT99944809 T AT 99944809T AT 99944809 T AT99944809 T AT 99944809T AT E234859 T1 ATE234859 T1 AT E234859T1
Authority
AT
Austria
Prior art keywords
function regulator
cir
development
regulator
present
Prior art date
Application number
AT99944809T
Other languages
English (en)
Inventor
Chieko Kitada
Shuji Hinuma
Chome
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE234859T1 publication Critical patent/ATE234859T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99944809T 1998-09-25 1999-09-24 Peptid-derivat ATE234859T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27162698 1998-09-25
PCT/JP1999/005216 WO2000018793A1 (fr) 1998-09-25 1999-09-24 Derive de peptide

Publications (1)

Publication Number Publication Date
ATE234859T1 true ATE234859T1 (de) 2003-04-15

Family

ID=17502707

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944809T ATE234859T1 (de) 1998-09-25 1999-09-24 Peptid-derivat

Country Status (8)

Country Link
EP (1) EP1116727B1 (de)
KR (1) KR20010085847A (de)
CN (1) CN1328568A (de)
AT (1) ATE234859T1 (de)
AU (1) AU5759399A (de)
CA (1) CA2343924A1 (de)
DE (1) DE69906108T2 (de)
WO (1) WO2000018793A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2391872A1 (en) * 1999-11-18 2001-05-25 Takeda Chemical Industries, Ltd. Use of peptides
EP1270585B1 (de) * 2000-03-23 2006-05-17 Takeda Chemical Industries, Ltd. Peptidderivat
WO2003063892A1 (en) * 2002-01-29 2003-08-07 Takeda Chemical Industries, Ltd. Use of apelin
US8673848B2 (en) 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
WO2007072980A1 (ja) 2005-12-20 2007-06-28 Takeda Pharmaceutical Company Limited アペリンの新規用途
EP1903052A3 (de) * 2006-07-28 2008-04-02 Faust Pharmaceuticals SA APJ Rezeptor-Liganden und deren Verwendung
WO2009033819A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
AU2008303922A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptide His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe alone or in combination with the peptide Gly-Ard-Gly-Asp-Asn-Pro-OH as a therapeutic agent
WO2010053545A2 (en) * 2008-11-04 2010-05-14 Anchor Therapeutics, Inc. Apj receptor compounds
RU2457216C1 (ru) * 2010-12-21 2012-07-27 Федеральное государственное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "РКНПК" Минздравсоцразвития России) Додекапептиды, обладающие кардиопротекторными свойствами
CN102863525B (zh) * 2011-07-04 2014-06-04 武汉大学 一种重组人apoE拟肽及制备方法和应用
US8921307B2 (en) 2012-11-20 2014-12-30 Novartis Ag Synthetic linear apelin mimetics for the treatment of heart failure
UY35144A (es) * 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
KR20160031551A (ko) 2013-07-25 2016-03-22 노파르티스 아게 심부전의 치료를 위한 시클릭 폴리펩티드
HK1218252A1 (zh) 2013-07-25 2017-02-10 Novartis Ag 合成apelin多肽之生物结合物
CN104436158A (zh) * 2013-09-22 2015-03-25 华中科技大学 Apelin-13在治疗糖尿病肾病中的应用
WO2015191781A2 (en) * 2014-06-10 2015-12-17 Amgen Inc. Apelin polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010033601A (ko) * 1997-12-24 2001-04-25 다케다 야쿠힌 고교 가부시키가이샤 폴리펩티드, 그의 제법 및 용도

Also Published As

Publication number Publication date
EP1116727A1 (de) 2001-07-18
EP1116727B1 (de) 2003-03-19
DE69906108D1 (de) 2003-04-24
AU5759399A (en) 2000-04-17
CN1328568A (zh) 2001-12-26
KR20010085847A (ko) 2001-09-07
WO2000018793A1 (fr) 2000-04-06
CA2343924A1 (en) 2000-04-06
DE69906108T2 (de) 2003-10-23
EP1116727A4 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
DE69906108D1 (de) Peptid-derivat
ATE326478T1 (de) Peptidderivat
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
TR199701557T2 (xx) Eritropoietin resept�r�ne ba�lanan bile�ikler ve peptidler.
DE69638023D1 (de) Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
TR199801041T2 (xx) Kanabinoid resept�r afinitesine sahip olan 3-pirazolkarboksamid t�revleri.
SE9901379D0 (sv) Receptor structures
DE69232137D1 (de) Multivalente antigen-bindende proteine
IT8223795A0 (it) Gamma), relativi veicoli di polipeptidi contenenti la sequenza espressione, loro procedimento di degli amminoacidi dell'interferone preparazione, composizioni umano immune (interferone umano farmaceutiche contenenti tali polipeptidi.
NO982794D0 (no) Diagnostisering og behandling av AUR-1 og/eller AUR-2 relaterte lidelser
AU1208497A (en) Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
ES8801729A1 (es) Un ensayo inmunometrio para proteina p21ras humana
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
PT996726E (pt) Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes
ES2150495T3 (es) Ligandos de flt3 purificados de mamifero y agonistas y antagonistas de los mismos.
EP0635016A4 (de) Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden.
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
ATE189232T1 (de) Protein-s polypeptide und deren verwendungen
DE69611037D1 (de) Methadonderivate und protein- und polypeptid-methadonkonjugate und markierte verbindungen
ATE86260T1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
Babila et al. Rat pineal Gsa, Gia and Goa: relative abundance and development
IT1284870B1 (it) Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
IT8921396A0 (it) Procedimento per la sintesi di peptidi preventivamente identificati come siti di interazione di proteine interagenti.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties